R D Jayasinghe1,2, P V K S Hettiarachchi1,2, Dilrukshi Amugoda3, Menaka Kumaraarachchi3, R L P R Liyanage4, B S M S Siriwardena2,5, Ranjith Gunasena3, A H T S Karunatilake6, H K Amarasinghe2,3. 1. Department of Oral Medicine and Periodontology, Faculty of Dental Sciences, University of Peradeniya, Sri Lanka. 2. Centre for Research in Oral cancer, Faculty of Dental Sciences, University of Peradeniya, Sri Lanka. 3. Institute of Oral Health, Maharagama, Sri Lanka. 4. National Dental Hospital, Colombo, Sri Lanka. 5. Department of Oral Pathology, Faculty of Dental Sciences, University of Peradeniya, Sri Lanka. 6. Colombo South Teaching Hospital, Kalubowila, Sri Lanka.
Abstract
INTRODUCTION: - Early detection plays a major role to reduce the mortality of oral squamous cell carcinoma (OSCC). Many adjunctive techniques have emerged with claims of differentiating high risk oral potentially malignant disorders (OPMDs) from benign lesions. Toluidine blue (TB) test has been established as a diagnostic adjunct in detecting high risk OPMDs and early asymptomatic OSCCs. As majority of OSCC are preceded by OPMDs, recognition of them at an early stage is important in the management of this devastating disease. METHODS: -This study was conducted as a multi-center study prospectively for a period of 2 years. Sixty five patients presented with OPMDs were selected and TB test was performed followed by a biopsy for histopathological confirmation. Criterion validity was assessed with histological diagnosis of the incisional biopsy of the OPMD as a gold standard test verses TB test results. RESULTS: The sensitivity of the TB test was 68.3% and the specificity 63.1% with a false positive rate of 36.8% and false negative rate of 31.7%. However, the predictive value of the positive test was 80%. CONCLUSION: - TB testing might be a potential adjunct diagnostic aid in identifying high risk OPMDs. Further studies with extensive sample size and different demographics are needed to validate our findings.
INTRODUCTION: - Early detection plays a major role to reduce the mortality of oral squamous cell carcinoma (OSCC). Many adjunctive techniques have emerged with claims of differentiating high risk oral potentially malignant disorders (OPMDs) from benign lesions. Toluidine blue (TB) test has been established as a diagnostic adjunct in detecting high risk OPMDs and early asymptomatic OSCCs. As majority of OSCC are preceded by OPMDs, recognition of them at an early stage is important in the management of this devastating disease. METHODS: -This study was conducted as a multi-center study prospectively for a period of 2 years. Sixty five patients presented with OPMDs were selected and TB test was performed followed by a biopsy for histopathological confirmation. Criterion validity was assessed with histological diagnosis of the incisional biopsy of the OPMD as a gold standard test verses TB test results. RESULTS: The sensitivity of the TB test was 68.3% and the specificity 63.1% with a false positive rate of 36.8% and false negative rate of 31.7%. However, the predictive value of the positive test was 80%. CONCLUSION: - TB testing might be a potential adjunct diagnostic aid in identifying high risk OPMDs. Further studies with extensive sample size and different demographics are needed to validate our findings.
Authors: Lewei Zhang; Michele Williams; Catherine F Poh; Denise Laronde; Joel B Epstein; Scott Durham; Hisae Nakamura; Ken Berean; Alan Hovan; Nhu D Le; Greg Hislop; Robert Priddy; John Hay; Wan L Lam; Miriam P Rosin Journal: Cancer Res Date: 2005-09-01 Impact factor: 12.701
Authors: Richard Macey; Tanya Walsh; Paul Brocklehurst; Alexander R Kerr; Joseph L Y Liu; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya; Crispian Scully Journal: Cochrane Database Syst Rev Date: 2015-05-29
Authors: Marta Mazur; Artnora Ndokaj; Divyambika Catakapatri Venugopal; Michela Roberto; Cristina Albu; Maciej Jedliński; Silverio Tomao; Iole Vozza; Grzegorz Trybek; Livia Ottolenghi; Fabrizio Guerra Journal: Int J Environ Res Public Health Date: 2021-11-10 Impact factor: 3.390
Authors: Tanya Walsh; Richard Macey; Alexander R Kerr; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya Journal: Cochrane Database Syst Rev Date: 2021-07-20